Froimson Mark has filed 8 insider transactions across 1 company since June 2023.
Most recent transaction: a sale of 500 shares of Pacira BioSciences, Inc. ($PCRX) on March 17, 2026.
Activity breakdown: 1 open-market purchase and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | S | Common Stock | 500 | $21.81 | 20,136.0000 | 45,729,000 | 2.42% | 0.00% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | A | Common Stock | 6163 | $0.00 | 20,636.0000 | 46,245,000 | 42.58% | 0.01% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | P | Common Stock | 1400 | $11.58 | 14,473.0000 | 51,979,000 | 10.71% | 0.00% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | A | Common Stock | 5230 | $0.00 | 13,073.0000 | 51,979,000 | 66.68% | 0.01% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | A | Common Stock | 1775 | $0.00 | 7,843.0000 | 46,538,000 | 29.25% | 0.00% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | Froimson Mark | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |